Lensar (LNSR) Free Cash Flow (2019 - 2026)
Lensar's (LNSR) quarterly Free Cash Flow came in at -$4.3 million in Q1 2026, up 38.49% year-on-year from -$3.1 million in Q1 2025, and down 791.1% on a QoQ basis from $618000.0 in Q4 2025.
Lensar (LNSR) Free Cash Flow (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Free Cash Flow data on file, last reported at -$4.3 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 38.49% year-over-year to -$4.3 million in Q1 2026; TTM through Mar 2026 was -$12.2 million, a 208.96% decrease from a year earlier, with the FY2025 full-year figure at -$14.9 million, down 513.49% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$4.3 million, down from $618000.0 in the prior quarter.
- Over the last five years, Free Cash Flow for LNSR reached as high as $3.7 million in Q4 2024 and fell as low as -$6.9 million in Q1 2025.
- Historically, Free Cash Flow has averaged -$2.7 million across 5 years, with a median of -$3.5 million in 2025.
- Across the five-year window, Free Cash Flow tumbled 437.99% in 2022 and jumped 1018.77% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$4.8 million in 2022, then jumped by 89.1% to -$525000.0 in 2023, then jumped by 796.0% to $3.7 million in 2024, then slumped by 83.09% to $618000.0 in 2025, then plunged by 791.1% to -$4.3 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$4.3 million in Q1 2026, $618000.0 in Q4 2025, and -$3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | 618,000.00 |
| Dec 31, 2025 | 618,000.00 |
| Sep 30, 2025 | -3.51 Mn |
| Sep 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | -5.08 Mn |
| Jun 30, 2025 | -5.08 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | -3.81 Mn |
| Jun 30, 2024 | -3.81 Mn |
| Mar 31, 2024 | -5.41 Mn |
| Mar 31, 2024 | -5.41 Mn |
| Dec 31, 2023 | -525,000.00 |
| Dec 31, 2023 | -525,000.00 |